AZD8848: Clinical Trials

2 trials of AZD8848, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow AZD8848: new trials by email Literature Review of AZD8848 trials Research Report on AZD8848

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848
AZD8848, Placebo, AZD8848 and placebo - Allergic Rhinitis
Phase 2CompletedAstraZeneca932010-09-012016-01-07
The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen
AZD8848, Placebo - Allergic Asthma
Phase 2CompletedAstraZeneca602009-10-012016-02-26

Conditions studied

Rhinitis, Allergic (1)

Sponsors

AstraZeneca (2)

Countries

Sweden (1)  ·  United Kingdom (1)

Top investigators

Brian Leaker, MD (1)  ·  Leif Eriksson, MD (1)  ·  Lennart Greiff, MD, PhD (1)  ·  Sam Lindgren, MD, PhD (1)

Results publications

PMID 26342289, PMID 31856838